Moreover, breast cancer was found to upregulate glypican-1 [120] and syndecan-4 [121] and to downregulate glypican-3 [122], whereas low expression of glypican-3 promotes tumor proliferation and metastasis [123]. Here, GPC3 is linked to neoplasm.